Countdown to Intuitive Surgical (ISRG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of Intuitive Surgical (ISRG) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Investment Research • 9 hours ago

Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know

Intuitive Surgical, Inc. (ISRG) reached $427.86 at the closing of the latest trading day, reflecting a +1.81% change compared to its last close.

Zacks Investment Research • 41 minutes ago

ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?

Intuitive Surgical shares have surged nearly 12% in a month ahead of Q3 earnings. Strong da Vinci 5 adoption and Ion growth fuel momentum, but valuation and risks linger.

Zacks Investment Research • Oct 14, 2026

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Investment Research • Oct 13, 2026

Intuitive Surgical (ISRG) Upgraded to Buy: Here's Why

Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Oct 13, 2026

ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters

Intuitive Surgical is targeting GI care with a next-generation robotic endoscope submitted to the FDA, opening a potential growth avenue beyond surgery.

Zacks Investment Research • Oct 13, 2026

3 Sales Growth Stocks to Buy as Q3 Earnings Get Underway

Chipotle, BP and Intuitive Surgical stand out for strong sales growth, solid cash flow and favorable valuation metrics as Q3 earnings begin.

Zacks Investment Research • Oct 13, 2026

Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?

Abbott Laboratories provides stability through a massive, diversified portfolio of diagnostics, nutrition, and medical devices. Intuitive Surgical dominates the robotic-assisted surgery market with high growth and exceptional cash reserves.

The Motley Fool • Oct 12, 2026

5 Companies Fighting for Control of the Next Robotics Boom

Symbotic (SYM +1.35%), Teradyne (TER +0.99%), ABB (ABBNY +1.81%), UiPath (PATH +1.74%), and Intuitive Surgical (ISRG +2.06%) offer five very different ways to invest in physical AI. The real opportunity may not belong to the flashiest robot, but to the company that controls the most valuable layer and can monetize it for years.

The Motley Fool • Oct 10, 2026

Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $423.96, signifying a +2.06% move from its prior day's close.

Zacks Investment Research • Oct 9, 2026